Table 3 Health outcomes and incremental cost-effectiveness results at 5 years
Costs (€) | Effects (QALYs) | ICER (€/QALY) | |||||
|---|---|---|---|---|---|---|---|
SPG | Control | Difference | SPG | Control | Difference | ||
Base case, 5 years, discounted | 42,187 | 41,298 | +889 | 2.87 | 2.55 | 0.32 | 2,736 |
Base case, 5 years, undiscounted | 42,998 | 44,475 | −1,477 | 3.09 | 2.74 | 0.35 | <0; SPG dominating |